Video

Cataract classification method allows for higher success rates of cataract surgery

Author(s):

Alex Dastgheib, MD, ABO, discusses the findings of the paper, "325 Cases of Phacoemulsification in Blind Cataracts," presented at the 2022 ASCRS conference in Washington, DC. The paper won the Challenging Cases session during the meeting.

The 325 cases were consecutively performed by Alex Dastgheib, MD, ABO, over a period of 8 years, from 2013 to 2020, and is the largest such case series reported in the world, according to databases Google Scholar, PubMed and a few others.

"I feel that you can make a complex or complicated case into something simple by following the surgical classification techniques. I think even a good resident should be able to be successful at these cataract surgeries if they follow the steps." Alex Dastgheib, MD, ABO

Key takeaways:

  • All cases were successful with a posterior chamber intraocular lens placed in every eye.
  • Through slightly different surgical techniques for each subgroup Dastgheib believes that helped to have such phenomenal results.
  • The results have been as good as the average cataract and the complication rate has been lower than the average cataract, including two (2) out of 325 posterior capsule ruptures.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Parag Majmudar, MD, on bridging the gap between residency and real-world practice
Brett Bielory, MD, discusses his poster at the ASCRS annual meeting, which focuses on an under-diagnosed corneal pathology: neurotrophic keratitis.
ASCRS 2025: Eva Kim, MD, discusses implantable collamer lenses and high myopia.
Abby Markward, MBA, and Hattie Hayes, editor of Ophthalmology Times Europe, discuss the ASCRS and ASOA meetings
Abby Markward discusses the ASCRS Foundation and the ASCRS Annual Meeting
(Image credit: Ophthalmology Times) Inside ASCRS 2025: Francis S. Mah, MD, takes the helm with a vision for research, education, and advocacy
© 2025 MJH Life Sciences

All rights reserved.